- Investigator
- Mark S Segal
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Cells, Cultured , 19 publications
- Biomarkers , 17 publications
- Kidney Failure, Chronic , 16 publications
- Hypertension , 16 publications
Research activity
Active clinical trials
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with…
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
- Ages
- 30 Years - 80 Years
- Sexes
- All
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
My publications
Filter publications
161 publications
2024
Mobile Electrocardiograms in the Detection of Subclinical Atrial Fibrillation in High-Risk Outpatient Populations: Protocol for an Observational Study
JMIR Research Protocols
•2024
Outcomes among Patients with End-Stage Kidney Disease and Chronic Limb-Threatening Ischemia: A Population-based Cohort Study.
Annals of surgery
•2023
Initiative to improve the quality of patient care for chronic dialysis patients in the inpatient setting.
Hemodialysis international. International Symposium on Home Hemodialysis
•2023
Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis.
Clinical immunology (Orlando, Fla.)
•2023
National Treatment Patterns and Outcomes for Hospitalized Patients with Chronic Limb-Threatening Ischemia and End-Stage Kidney Disease.
Vascular and endovascular surgery
•